Home > Archive > 2002 >

Volume 21, Number 1 (March)

Gestational Diabetes Mellitus (pages 7-13)

Meeta Sharma, M.D., and Robert Ratner, M.D.

Gestational diabetes mellitus (GDM) can lead to macrosomia, death of the fetus, and later development of diabetes for the mother and child. Several competing screening tests for GDM exist, which can be confusing for health-care providers. The authors discuss a recommended screening method for and how to decide who should be screened.
Gestational diabetes

New Insulin Therapies for the Management of Diabetes Mellitus (pages 14-20)

Anna Kissin, M.D., and Harvey L. Katzeff, M.D.

Tight blood glucose control has been shown to reduce the risks of developing diabetes complications. In this article, the authors discuss how to select an appropriate insulin regimen to help patients with Type 1 or Type 2 diabetes improve their glycemic control.
Drug treatmentInsulin
Management strategies and toolsStrategies for glycemic control

NCEP ATP III Guidelines (pages 21-28)

Charles M. Alexander, M.D., Suzanne Antonello, C.T.(A.S.C.P.), Christine Heggan, B.S., and Robert A. Calder, M.D.

Nearly two-thirds of people with diabetes will die from cardiovascular disease. This article reviews the latest cholesterol guidelines from the National Cholesterol Education Program with a special slant: assessing and treating cholesterol problems in your patients with diabetes.
Professional guidelines
Drug treatmentCholesterol-lowering drugs

Collaborative Diabetes Care (pages 29-32)

Richard R. Rubin, Ph.D., C.D.E., Robert M. Anderson, Ed.D., and Martha M. Funnell, R.N., M.S., C.D.E.

Health professionals are trained to provide care, yet with diseases such as diabetes, patients make most of the clinically relevant decisions. This article explains how you can facilitate more healthful self-care behaviors in your patients.
Health services and insurance

Basal-Bolus Insulin Therapy (pages 33-36)

Geralyn R. Spollett, M.S.N., A.N.P., C.D.E.

The goal of multiple daily injection therapy is to mimic physiologic insulin patterns to prevent long-term diabetic complications. The author show how using the new long-acting insulin glargine, along with mealtime doses of a rapid-acting insulin can help people with diabetes achieve this important goal.
Drug treatmentInsulin

Who's in Charge Here? (pages 40-41)

Daniel L. Lorber, M.D.

Point-of-service determinations of HbA1c levels have been shown to improve patient glycemic control and decision-making. Why do some insurers refuse to reimburse for this test?
Health services and insurance
Management strategies and toolsHbA1c testing